Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Modern Breast Cancer Imaging
| Modern Breast Cancer Imaging |
| Autore | Kim Hsieh Su Jin |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing AG, , 2021 |
| Descrizione fisica | 1 online resource (466 pages) |
| Altri autori (Persone) | MorrisElizabeth Anne |
| Soggetto genere / forma | Electronic books. |
| ISBN | 3-030-84546-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Contents -- Contributors -- Part I: Updates in Clinical and Pathological Aspects for Breast Cancer -- Chapter 1: Molecular Basis of Breast Cancer -- 1.1 Introduction -- 1.2 BC (Basal Carcinomas) and TNC (Triple Negative Carcinomas) -- 1.3 Luminal Carcinomas (LC) -- 1.4 HER2-Enriched Carcinomas -- References -- Chapter 2: Risk Factors for Breast Cancer -- 2.1 Introduction -- 2.2 Gender and Age -- 2.3 Reproductive Factors -- 2.4 Gestation and Lactation -- 2.5 Contraception and Hormone Replacement Therapy -- 2.6 Obesity -- 2.7 Alcohol and Smoking -- 2.8 Thoracic Radiation Therapy -- 2.9 Precursor Injuries -- 2.10 Hereditary Syndromes and Breast Cancer -- 2.11 Genes and Associated Syndromes -- 2.11.1 Genes Associated with High Penetrance -- 2.11.2 Genes Associated with Moderate Penetrance -- 2.12 Quantification of Mutation Risk -- 2.13 Genetic Testing for High-Risk Patients -- References -- Chapter 3: Genomic Tests -- 3.1 Introduction -- 3.2 Gene Expression Assays -- 3.2.1 Oncotype DX -- 3.2.2 MammaPrint -- 3.2.3 Other Assays -- 3.3 Concordance of Expression Assays -- 3.4 Conclusion -- References -- Chapter 4: Updates in Surgical Approaches for Breast and Axilla -- 4.1 Introduction -- 4.2 Axillary Management in Clinically Node-Negative Patients with Invasive Breast Cancer -- 4.3 Axillary Management in Micrometastases (N1m1) or Isolated Tumor Cells N (+1) Patients with Invasive Breast Cancer -- 4.4 Axillary Management in Clinically Node-Negative Patients and Macrometastases in the Pathology with Invasive Breast Cancer -- 4.5 Axillary Management in Clinically Node-Positive Patients and Neoadjuvant Chemotherapy (NAC) Treatment -- References -- Chapter 5: Pathological Aspects for Diagnosis -- 5.1 Pre-analytical Procedures -- 5.2 Radiological-Pathological Correlation -- 5.3 Fibroepithelial Lesions -- 5.4 Papillary Neoplasms.
5.5 Benign High-Risk Lesions and Precursors, Including Classic Lobular Intraepithelial Neoplasia -- 5.6 Atypical Ductal Hyperplasia and Low-Grade Carcinoma In Situ -- 5.7 Intermediate and High-Grade Ductal Carcinoma In Situ -- 5.8 Pleomorphic Lobular Carcinoma In Situ (PLCIS) -- 5.9 Biomarkers in Ductal Carcinoma In Situ -- 5.10 Invasive Carcinoma of No Special Type -- 5.11 Macroscopic Evaluation of the Breast Specimen, Including Those with Neoadjuvant Treatment -- 5.12 Special Subtypes -- 5.13 Special Methods -- 5.13.1 Immunohistochemistry -- 5.13.2 In Situ Hybridization -- 5.14 Next-Generation Sequencing (NGS) -- References -- Part II: Update in Imaging Method -- Chapter 6: Radiation Based Imaging: Digital Mammography, Tomosynthesis -- 6.1 Introduction -- 6.2 Technique -- 6.3 Indications -- 6.4 Interpretation -- 6.4.1 Breast Composition -- 6.4.2 Masses -- 6.4.3 Calcifications -- 6.4.4 Architectural Distortion -- 6.4.5 Asymmetries -- 6.4.6 Intramammary Lymph Node -- 6.4.7 Skin Lesions -- 6.4.8 Single Dilated Duct -- 6.4.9 Associated Findings -- 6.4.10 Location of Lesions -- 6.4.11 ACR-BI-RADS® Final Assessment -- 6.4.12 Recommendation -- 6.5 Conclusions -- References -- Chapter 7: Sonographic Based Imaging: Ultrasound, Color Doppler, Elastography, and Automated Breast Imaging -- 7.1 Introduction -- 7.2 Scanning Technique -- 7.2.1 The Ideal Image -- 7.2.2 Anatomy -- 7.2.3 Harmonic -- 7.2.4 Compound Imaging -- 7.3 Doppler Evaluation -- 7.4 Elastography -- 7.4.1 Strain Elastography -- 7.4.2 Shear Wave Elastography -- 7.5 Automated Breast Ultrasound -- 7.6 Correlation with Other Imaging Methods -- 7.7 Exam Documentation -- 7.8 BI-RADS® Lexicon -- 7.9 Report and Assessment -- 7.9.1 BI-RADS® Categories -- References -- Chapter 8: Magnetic Resonance Imaging: Regular Protocols and Fast Protocols -- 8.1 Introduction -- 8.2 Standard Examination. 8.3 T2-Weighted Images -- 8.4 T1-Weighted Images -- 8.5 Subtraction, Enhancement Curve, and 3D MIP -- 8.6 Diffusion-Weighted Images -- 8.7 Breast Implants -- 8.8 Abbreviated Protocol -- 8.9 Ultrafast Breast MRI -- 8.10 Conclusion -- References -- Chapter 9: Nuclear Medicine Based Methods: PET FDG and Other Tracers -- 9.1 Introduction -- 9.1.1 Basic Aspects of 18F-FDG-PET -- 9.2 18F-FDG-PET/CT Indications in Breast Cancer -- 9.2.1 Primary Breast Tumor Detection and Staging (T) -- 9.2.2 Nodal Staging (N) -- 9.2.3 Metastatic Staging (M) -- 9.2.4 Recurrence -- 9.2.5 Response Assessment to Neoadjuvant Chemotherapy (NAC) -- 9.2.6 Response Assessment in Metastatic Disease -- 9.3 Prognostic Value -- 9.4 Other PET Technologies and Tracers -- 9.4.1 PET/MR and Positron Emission Mammography (PEM) -- 9.4.2 Non-FDG Tracers for Breast Cancer -- 9.5 Conclusion -- References -- Chapter 10: Image-Guided Percutaneous Biopsies -- 10.1 Historical Perspective -- 10.2 Understanding Imaging-Guidance and Needle Selection: Practical Considerations -- 10.3 Pre-biopsy Assessment -- 10.4 Patient Preparation, Biopsy Risks, and General Post-biopsy Information -- 10.5 Considerations Regarding Clip Placement -- 10.6 Clip Placement Complications -- 10.7 Ultrasound-Guided Biopsy -- 10.8 Fine-Needle Aspiration (FNA) -- 10.8.1 Axillary Assessment -- 10.8.2 Cysts -- 10.8.3 Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) -- 10.8.4 Challenging Lesion Location -- 10.8.5 Diagnostic Accuracy and Availability -- 10.9 Technique -- 10.10 Complications and Post-care -- 10.10.1 Ultrasound-Guided Core Needle Biopsy and Vacuum-Assisted Biopsy -- 10.10.2 Sampling Considerations -- 10.11 Quantity and Quality of the Sample -- 10.12 Adequate Targeting -- 10.13 Choosing Between VAB and CNB -- 10.13.1 Therapeutic VAB -- 10.13.2 VAB and CNB Technique -- 10.14 Mammography-Guided Biopsy. 10.15 Stereotactic Biopsy -- 10.16 Upright Add-On and Prone Table Biopsy Systems -- 10.17 The Procedure -- 10.18 Digital Breast Tomosynthesis-Guided Biopsy -- 10.19 DBT Versus Stereotactic Guided Biopsy -- 10.20 The Procedure -- 10.21 Technical Challenges and Possible Solutions (DBT and Stereotactic Biopsy) -- 10.21.1 Subtle Findings -- 10.21.2 Far Posterior Lesions -- 10.21.3 Thin Breasts -- 10.22 Superficial Lesions -- 10.23 MRI-Guided Biopsy -- 10.23.1 Second-Look Ultrasound and Second-Look Mammography -- 10.23.2 Second-Look Mammography -- 10.23.3 The Procedure -- 10.23.4 Complications and Post-biopsy Care -- 10.24 Imaging-Pathology Correlation -- 10.25 Discordant Biopsy -- 10.25.1 Concordant Malignancy -- 10.25.1.1 Discordant Malignancy -- 10.25.2 Concordant Benign -- 10.25.3 Discordant Benign -- 10.25.4 High-Risk and Borderline Lesions -- References -- Chapter 11: Breast Imaging Preoperative Localization Procedure -- 11.1 Introduction -- 11.2 Indications of Preoperative Localization -- 11.3 Pre-procedure Review of Preoperative Localization -- 11.4 Wire Localization -- 11.4.1 MG-Guided and Stereotactic-Guided Wire Localization -- 11.4.1.1 Technique Using a Perforated or Marked Compression Plate -- 11.4.1.2 Technique Using a Stereotactic Table -- 11.4.2 US-Guided Wire Localization -- 11.4.3 MRI-Guided Wire Localization -- 11.4.4 Wire Variations -- 11.5 Nonwire Localization Methods -- 11.5.1 Carbon Marking -- 11.5.2 Radio-Guided Occult Lesion Localization (ROLL) -- 11.5.2.1 Sentinel Node and Occult Lesion Localization (SNOLL) -- 11.5.3 Current Lesion Localization Techniques -- 11.5.3.1 Radioactive Nonwire Localization Device -- Radioactive Seed Localization -- 11.5.3.2 Non-radioactive Wireless Localization Devices -- Radar Reflector Localization -- Magnetic Seed Localization -- Radiofrequency Identification Tag (RFID) Localization. 11.6 Post-procedure Complications -- 11.7 Post-procedure Assessment -- References -- Part III: Different Clinical Scenario: Clinical Management and Role of Imaging Modalities -- Chapter 12: Screening -- 12.1 Introduction -- 12.2 Screen-Film Mammography -- 12.3 Digital Mammography -- 12.4 Tomosynthesis -- 12.5 Magnetic Resonance Imaging (MRI) -- 12.6 Ultrasound -- 12.7 Molecular Breast Imaging -- 12.8 Clinical Breast Examination -- 12.9 Breast Self-Examination -- 12.10 Thermography -- 12.11 Elastography -- 12.12 Screening in Special Populations -- 12.12.1 Increased Breast Density -- 12.12.2 High-Risk of Breast Cancer -- 12.12.3 Elderly Women -- References -- Chapter 13: Diagnostic -- 13.1 Diagnostic Management of Clinical Situations -- 13.1.1 Palpable Changes of the Breast -- 13.1.1.1 Breast Lump -- 13.1.1.2 Paget Disease -- 13.1.1.3 Occult Breast Cancer and Axillary Lymphadenopathy -- 13.1.2 Non-palpable Breast Changes -- 13.1.2.1 Image Screening Findings -- 13.1.2.2 Nipple Discharge -- 13.1.3 Breast Biopsy in Clinical Scenario -- 13.1.3.1 US and Mammography-Guided Biopsy (Fine-Needle Aspiration (FNA)/Core-Needle Biopsy (CNB)/Vacuum Aspiration Biopsy (VAB)) -- 13.1.3.2 MRI- and DBT-Guided Biopsy -- References -- Chapter 14: Preoperative (Breast) -- 14.1 Preoperative Tests for the Breast -- 14.1.1 Imaging Methods -- 14.1.1.1 Mammography -- 14.1.1.2 Ultrasound -- 14.1.1.3 Tomosynthesis -- 14.1.1.4 Breast Magnetic Resonance Imaging -- 14.1.1.5 Positron Emission Tomography-Computed Tomography (PET-CT) -- 14.2 Preoperative Tests for the Axilla -- 14.2.1 Indications -- 14.2.2 Methods -- 14.2.2.1 Ultrasound -- 14.2.2.2 Mammography -- 14.2.2.3 Magnetic Resonance Imaging -- 14.2.2.4 PET-CT -- 14.3 Case Examples -- 14.3.1 Case 1 -- 14.3.2 Case 2 -- 14.3.3 Case 3 -- 14.3.4 Case 4 -- 14.3.5 Case 5 -- References. Chapter 15: Systemic Staging (Total Body - When, How). |
| Record Nr. | UNINA-9910508468903321 |
Kim Hsieh Su Jin
|
||
| Cham : , : Springer International Publishing AG, , 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern breast cancer imaging / / Su Jin Kim Hsieh, Elizabeth Anne Morris, editors
| Modern breast cancer imaging / / Su Jin Kim Hsieh, Elizabeth Anne Morris, editors |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2022] |
| Descrizione fisica | 1 online resource (466 pages) |
| Disciplina | 616.99449075 |
| Soggetto topico |
Breast - Cancer
Breast - Cancer - Treatment Technological innovations Breast Neoplasms - diagnostic imaging Breast Neoplasms - therapy Image Processing, Computer-Assisted |
| ISBN | 3-030-84546-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Foreword -- Preface -- Contents -- Contributors -- Part I: Updates in Clinical and Pathological Aspects for Breast Cancer -- Chapter 1: Molecular Basis of Breast Cancer -- 1.1 Introduction -- 1.2 BC (Basal Carcinomas) and TNC (Triple Negative Carcinomas) -- 1.3 Luminal Carcinomas (LC) -- 1.4 HER2-Enriched Carcinomas -- References -- Chapter 2: Risk Factors for Breast Cancer -- 2.1 Introduction -- 2.2 Gender and Age -- 2.3 Reproductive Factors -- 2.4 Gestation and Lactation -- 2.5 Contraception and Hormone Replacement Therapy -- 2.6 Obesity -- 2.7 Alcohol and Smoking -- 2.8 Thoracic Radiation Therapy -- 2.9 Precursor Injuries -- 2.10 Hereditary Syndromes and Breast Cancer -- 2.11 Genes and Associated Syndromes -- 2.11.1 Genes Associated with High Penetrance -- 2.11.2 Genes Associated with Moderate Penetrance -- 2.12 Quantification of Mutation Risk -- 2.13 Genetic Testing for High-Risk Patients -- References -- Chapter 3: Genomic Tests -- 3.1 Introduction -- 3.2 Gene Expression Assays -- 3.2.1 Oncotype DX -- 3.2.2 MammaPrint -- 3.2.3 Other Assays -- 3.3 Concordance of Expression Assays -- 3.4 Conclusion -- References -- Chapter 4: Updates in Surgical Approaches for Breast and Axilla -- 4.1 Introduction -- 4.2 Axillary Management in Clinically Node-Negative Patients with Invasive Breast Cancer -- 4.3 Axillary Management in Micrometastases (N1m1) or Isolated Tumor Cells N (+1) Patients with Invasive Breast Cancer -- 4.4 Axillary Management in Clinically Node-Negative Patients and Macrometastases in the Pathology with Invasive Breast Cancer -- 4.5 Axillary Management in Clinically Node-Positive Patients and Neoadjuvant Chemotherapy (NAC) Treatment -- References -- Chapter 5: Pathological Aspects for Diagnosis -- 5.1 Pre-analytical Procedures -- 5.2 Radiological-Pathological Correlation -- 5.3 Fibroepithelial Lesions -- 5.4 Papillary Neoplasms.
5.5 Benign High-Risk Lesions and Precursors, Including Classic Lobular Intraepithelial Neoplasia -- 5.6 Atypical Ductal Hyperplasia and Low-Grade Carcinoma In Situ -- 5.7 Intermediate and High-Grade Ductal Carcinoma In Situ -- 5.8 Pleomorphic Lobular Carcinoma In Situ (PLCIS) -- 5.9 Biomarkers in Ductal Carcinoma In Situ -- 5.10 Invasive Carcinoma of No Special Type -- 5.11 Macroscopic Evaluation of the Breast Specimen, Including Those with Neoadjuvant Treatment -- 5.12 Special Subtypes -- 5.13 Special Methods -- 5.13.1 Immunohistochemistry -- 5.13.2 In Situ Hybridization -- 5.14 Next-Generation Sequencing (NGS) -- References -- Part II: Update in Imaging Method -- Chapter 6: Radiation Based Imaging: Digital Mammography, Tomosynthesis -- 6.1 Introduction -- 6.2 Technique -- 6.3 Indications -- 6.4 Interpretation -- 6.4.1 Breast Composition -- 6.4.2 Masses -- 6.4.3 Calcifications -- 6.4.4 Architectural Distortion -- 6.4.5 Asymmetries -- 6.4.6 Intramammary Lymph Node -- 6.4.7 Skin Lesions -- 6.4.8 Single Dilated Duct -- 6.4.9 Associated Findings -- 6.4.10 Location of Lesions -- 6.4.11 ACR-BI-RADS® Final Assessment -- 6.4.12 Recommendation -- 6.5 Conclusions -- References -- Chapter 7: Sonographic Based Imaging: Ultrasound, Color Doppler, Elastography, and Automated Breast Imaging -- 7.1 Introduction -- 7.2 Scanning Technique -- 7.2.1 The Ideal Image -- 7.2.2 Anatomy -- 7.2.3 Harmonic -- 7.2.4 Compound Imaging -- 7.3 Doppler Evaluation -- 7.4 Elastography -- 7.4.1 Strain Elastography -- 7.4.2 Shear Wave Elastography -- 7.5 Automated Breast Ultrasound -- 7.6 Correlation with Other Imaging Methods -- 7.7 Exam Documentation -- 7.8 BI-RADS® Lexicon -- 7.9 Report and Assessment -- 7.9.1 BI-RADS® Categories -- References -- Chapter 8: Magnetic Resonance Imaging: Regular Protocols and Fast Protocols -- 8.1 Introduction -- 8.2 Standard Examination. 8.3 T2-Weighted Images -- 8.4 T1-Weighted Images -- 8.5 Subtraction, Enhancement Curve, and 3D MIP -- 8.6 Diffusion-Weighted Images -- 8.7 Breast Implants -- 8.8 Abbreviated Protocol -- 8.9 Ultrafast Breast MRI -- 8.10 Conclusion -- References -- Chapter 9: Nuclear Medicine Based Methods: PET FDG and Other Tracers -- 9.1 Introduction -- 9.1.1 Basic Aspects of 18F-FDG-PET -- 9.2 18F-FDG-PET/CT Indications in Breast Cancer -- 9.2.1 Primary Breast Tumor Detection and Staging (T) -- 9.2.2 Nodal Staging (N) -- 9.2.3 Metastatic Staging (M) -- 9.2.4 Recurrence -- 9.2.5 Response Assessment to Neoadjuvant Chemotherapy (NAC) -- 9.2.6 Response Assessment in Metastatic Disease -- 9.3 Prognostic Value -- 9.4 Other PET Technologies and Tracers -- 9.4.1 PET/MR and Positron Emission Mammography (PEM) -- 9.4.2 Non-FDG Tracers for Breast Cancer -- 9.5 Conclusion -- References -- Chapter 10: Image-Guided Percutaneous Biopsies -- 10.1 Historical Perspective -- 10.2 Understanding Imaging-Guidance and Needle Selection: Practical Considerations -- 10.3 Pre-biopsy Assessment -- 10.4 Patient Preparation, Biopsy Risks, and General Post-biopsy Information -- 10.5 Considerations Regarding Clip Placement -- 10.6 Clip Placement Complications -- 10.7 Ultrasound-Guided Biopsy -- 10.8 Fine-Needle Aspiration (FNA) -- 10.8.1 Axillary Assessment -- 10.8.2 Cysts -- 10.8.3 Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) -- 10.8.4 Challenging Lesion Location -- 10.8.5 Diagnostic Accuracy and Availability -- 10.9 Technique -- 10.10 Complications and Post-care -- 10.10.1 Ultrasound-Guided Core Needle Biopsy and Vacuum-Assisted Biopsy -- 10.10.2 Sampling Considerations -- 10.11 Quantity and Quality of the Sample -- 10.12 Adequate Targeting -- 10.13 Choosing Between VAB and CNB -- 10.13.1 Therapeutic VAB -- 10.13.2 VAB and CNB Technique -- 10.14 Mammography-Guided Biopsy. 10.15 Stereotactic Biopsy -- 10.16 Upright Add-On and Prone Table Biopsy Systems -- 10.17 The Procedure -- 10.18 Digital Breast Tomosynthesis-Guided Biopsy -- 10.19 DBT Versus Stereotactic Guided Biopsy -- 10.20 The Procedure -- 10.21 Technical Challenges and Possible Solutions (DBT and Stereotactic Biopsy) -- 10.21.1 Subtle Findings -- 10.21.2 Far Posterior Lesions -- 10.21.3 Thin Breasts -- 10.22 Superficial Lesions -- 10.23 MRI-Guided Biopsy -- 10.23.1 Second-Look Ultrasound and Second-Look Mammography -- 10.23.2 Second-Look Mammography -- 10.23.3 The Procedure -- 10.23.4 Complications and Post-biopsy Care -- 10.24 Imaging-Pathology Correlation -- 10.25 Discordant Biopsy -- 10.25.1 Concordant Malignancy -- 10.25.1.1 Discordant Malignancy -- 10.25.2 Concordant Benign -- 10.25.3 Discordant Benign -- 10.25.4 High-Risk and Borderline Lesions -- References -- Chapter 11: Breast Imaging Preoperative Localization Procedure -- 11.1 Introduction -- 11.2 Indications of Preoperative Localization -- 11.3 Pre-procedure Review of Preoperative Localization -- 11.4 Wire Localization -- 11.4.1 MG-Guided and Stereotactic-Guided Wire Localization -- 11.4.1.1 Technique Using a Perforated or Marked Compression Plate -- 11.4.1.2 Technique Using a Stereotactic Table -- 11.4.2 US-Guided Wire Localization -- 11.4.3 MRI-Guided Wire Localization -- 11.4.4 Wire Variations -- 11.5 Nonwire Localization Methods -- 11.5.1 Carbon Marking -- 11.5.2 Radio-Guided Occult Lesion Localization (ROLL) -- 11.5.2.1 Sentinel Node and Occult Lesion Localization (SNOLL) -- 11.5.3 Current Lesion Localization Techniques -- 11.5.3.1 Radioactive Nonwire Localization Device -- Radioactive Seed Localization -- 11.5.3.2 Non-radioactive Wireless Localization Devices -- Radar Reflector Localization -- Magnetic Seed Localization -- Radiofrequency Identification Tag (RFID) Localization. 11.6 Post-procedure Complications -- 11.7 Post-procedure Assessment -- References -- Part III: Different Clinical Scenario: Clinical Management and Role of Imaging Modalities -- Chapter 12: Screening -- 12.1 Introduction -- 12.2 Screen-Film Mammography -- 12.3 Digital Mammography -- 12.4 Tomosynthesis -- 12.5 Magnetic Resonance Imaging (MRI) -- 12.6 Ultrasound -- 12.7 Molecular Breast Imaging -- 12.8 Clinical Breast Examination -- 12.9 Breast Self-Examination -- 12.10 Thermography -- 12.11 Elastography -- 12.12 Screening in Special Populations -- 12.12.1 Increased Breast Density -- 12.12.2 High-Risk of Breast Cancer -- 12.12.3 Elderly Women -- References -- Chapter 13: Diagnostic -- 13.1 Diagnostic Management of Clinical Situations -- 13.1.1 Palpable Changes of the Breast -- 13.1.1.1 Breast Lump -- 13.1.1.2 Paget Disease -- 13.1.1.3 Occult Breast Cancer and Axillary Lymphadenopathy -- 13.1.2 Non-palpable Breast Changes -- 13.1.2.1 Image Screening Findings -- 13.1.2.2 Nipple Discharge -- 13.1.3 Breast Biopsy in Clinical Scenario -- 13.1.3.1 US and Mammography-Guided Biopsy (Fine-Needle Aspiration (FNA)/Core-Needle Biopsy (CNB)/Vacuum Aspiration Biopsy (VAB)) -- 13.1.3.2 MRI- and DBT-Guided Biopsy -- References -- Chapter 14: Preoperative (Breast) -- 14.1 Preoperative Tests for the Breast -- 14.1.1 Imaging Methods -- 14.1.1.1 Mammography -- 14.1.1.2 Ultrasound -- 14.1.1.3 Tomosynthesis -- 14.1.1.4 Breast Magnetic Resonance Imaging -- 14.1.1.5 Positron Emission Tomography-Computed Tomography (PET-CT) -- 14.2 Preoperative Tests for the Axilla -- 14.2.1 Indications -- 14.2.2 Methods -- 14.2.2.1 Ultrasound -- 14.2.2.2 Mammography -- 14.2.2.3 Magnetic Resonance Imaging -- 14.2.2.4 PET-CT -- 14.3 Case Examples -- 14.3.1 Case 1 -- 14.3.2 Case 2 -- 14.3.3 Case 3 -- 14.3.4 Case 4 -- 14.3.5 Case 5 -- References. Chapter 15: Systemic Staging (Total Body - When, How). |
| Record Nr. | UNINA-9910523804803321 |
| Cham, Switzerland : , : Springer, , [2022] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||